Portfolio > HypnoVR

logo hypnovr.png

Investment: HypnoVR

Entry date:           October 2021

Investment type:  Growth Capital

Participation:       Minority

Head Office:         Strasbourg - France

Revenues:            <EUR 5m

Activities:

HypnoVR specializes in the development of digital therapies that combine medical hypnosis and virtual reality, for the management of pain and stress. It designs, develops and markets software applications and medical devices as innovative tools of hypnosedation to improve the quality of care and comfort for patients. Its solutions can be seamlessly integrated into multimodal accelerated rehabilitation procedures and help improve the care provided throughout the entire pathway.

They can be used in multiple medical specialties including anesthesia and critical care, surgery, dental care and imaging. Its technology received CE marking as a Class 1 medical device in September 2018.

 Why Akiles was selected:

We are delighted with this new funding round involving a group of European investors. This funding shows the relevance and international potential of our medical hypnosis technology when it comes to reducing pain and anxiety. It also confirms that we are recognized as a leader in this field.

Why Akiles invested :

HypnoVR illustrates perfectly the potential benefits that digital technology can bring to the daily lives of patients and healthcare professionals. What really convinced us was the experience of the team and the numerous possibilities opened up by the company’s pioneering technology, which offers healthcare professionals an additional tool to care for patients both in hospital and private practice.

250GrowthCapital_edited.png
product-edited-1024x577.jpeg
Capture d’écran 2022-03-27 à 18.17.33.png
hypno_people.jpeg